High Free Cash Flow Stocks
FAGR.BR is currently part of our High Free Cash Flow Stocks screen, indicating it generates strong cash flows relative to its price.
EBR:FAGR • BE0003874915
The current stock price of FAGR.BR is 23.95 EUR. Today FAGR.BR is down by -1.44%. In the past month the price increased by 10.62%. In the past year, price increased by 23.84%.
FAGR.BR currently appears in the following ChartMill screener lists.
FAGR.BR is currently part of our High Free Cash Flow Stocks screen, indicating it generates strong cash flows relative to its price.
FAGR.BR is part of our Dividend Growth Stocks screen, indicating it has a reliable dividend with grows strongly
FAGR.BR is part of our Strong Buy Rated Stocks screen, indicating it has a strong buy ratings from analysts and supporting business quality.
FAGR.BR is forming a bull flag pattern, suggesting a potential continuation of its upward trend.
FAGR.BR appears in our Breakout Setups screen. This means the stock shows strong technical strength, a constructive consolidation pattern, and enough volatility to support a potential breakout if price moves above resistance.
FAGR.BR is part of our growth-at-reasonable-price stock list, indicating it is growing while not too expensive.
ChartMill assigns a technical rating of 8 / 10 to FAGR.BR. When comparing the yearly performance of all stocks, FAGR.BR turns out to be only a medium performer in the overall market: it outperformed 63.65% of all stocks.
ChartMill assigns a fundamental rating of 6 / 10 to FAGR.BR. FAGR.BR scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
13 analysts have analysed FAGR.BR and the average price target is 28.49 EUR. This implies a price increase of 18.94% is expected in the next year compared to the current price of 23.95.
For the next year, analysts expect an EPS growth of 15.05% and a revenue growth 18.14% for FAGR.BR
Over the last trailing twelve months FAGR.BR reported a non-GAAP Earnings per Share(EPS) of 1.24. The EPS increased by 12.66% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.56% | ||
| ROA | 7.32% | ||
| ROE | 16.5% | ||
| Debt/Equity | 0.83 |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| AXNA | AMPLIFON SPA | 15.34 | 2.302B | ||
| AMP | AMPLIFON SPA | 15.11 | 2.266B | ||
| UPR | UNIPHAR PLC | 16.28 | 1.085B | ||
| ILM1 | MEDIOS AG | 10.92 | 342.089M | ||
| BLC | BASTIDE LE CONFORT MEDICAL | 12.53 | 190.883M | ||
| PRE | PREDICT SPA | N/A | 4.345M | ||
| VME | VIROMED MEDICAL AG | N/A |
View all stocks in the Health Care Distributors Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Brussels Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
Fagron NV engages in the development, marketing, and distribution of healthcare products and services. The company is headquartered in Nazareth, Oost-Vlaanderen and currently employs 4,297 full-time employees. The company went IPO on 2007-10-05. The firm specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. The company operates through the following segments: Essentials, enable pharmacists to compound safe products and optimize their compounding process with equipment and packaging. The portfolio includes pharmaceutical raw materials, compounding equipment, packaging, and supplies; Brands, focuses on developing semi-finished products and pharmaceutical-grade vehicles and reduce the workload for pharmacists; Compounding Services, utilizes raw materials from the Essentials segment and vehicles from the Brands segment for compounding activities, offering both sterile and non-sterile compounded products tailored to patients' specific needs.
IPO: 2007-10-05
FAGRON
Venecoweg 20A
Nazareth OOST-VLAANDEREN BE
Employees: 4193
Phone: 3280012880
Fagron NV engages in the development, marketing, and distribution of healthcare products and services. The company is headquartered in Nazareth, Oost-Vlaanderen and currently employs 4,297 full-time employees. The company went IPO on 2007-10-05. The firm specializes in the development, marketing and distribution of healthcare products and services intended for healthcare professionals and institutions. The company operates through the following segments: Essentials, enable pharmacists to compound safe products and optimize their compounding process with equipment and packaging. The portfolio includes pharmaceutical raw materials, compounding equipment, packaging, and supplies; Brands, focuses on developing semi-finished products and pharmaceutical-grade vehicles and reduce the workload for pharmacists; Compounding Services, utilizes raw materials from the Essentials segment and vehicles from the Brands segment for compounding activities, offering both sterile and non-sterile compounded products tailored to patients' specific needs.
The current stock price of FAGR.BR is 23.95 EUR. The price decreased by -1.44% in the last trading session.
FAGRON (FAGR.BR) has a dividend yield of 1.18%. The yearly dividend amount is currently 0.36.
FAGR.BR has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
FAGR.BR stock is listed on the Euronext Brussels exchange.
FAGRON (FAGR.BR) operates in the Health Care sector and the Health Care Providers & Services industry.